• Profile
Close

Iron overload in functional hyperandrogenism: In a randomized trial, bloodletting does not improve metabolic outcomes

Journal of Clinical Endocrinology and Metabolism Jan 22, 2021

Ortiz-Flores AE, Martínez-García MÁ, Nattero-Chávez L, et al. - In this randomized, parallel, open-label, clinical trial, researchers sought to determine the impact of iron depletion on the insulin sensitivity and frequency of abnormal glucose tolerance in patients with functional hyperandrogenism submitted to standard therapy with combined oral contraceptives (COC), as well as to evaluate the overall safety of this intervention. Participants in the study were adult women with polycystic ovary syndrome or idiopathic hyperandrogenism. Thirty-three women were included by intention-to-treat from 2015 to 2019. In women with functional hyperandrogenism on COC, scheduled bloodletting does not improve insulin sensitivity. Women in the experimental arm displayed comparable chances of having prediabetes/diabetes than women submitted to observation.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay